Pharmacovigilance

Serious Adverse Event(SAE)

An adverse event that results in death, is life-threatening, requires hospitalization, causes disability, or is a congenital anomaly.

Usage Examples

The SAE required 7-day expedited reporting due to fatal outcome.
The DSMB reviewed all SAEs at the interim analysis.
SAE reconciliation identified discrepancies between CRF and safety database.

What is SAE?

A Serious Adverse Event (SAE) is any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, or is an important medical event.

SAEs require expedited reporting to regulatory authorities. Unexpected SAEs suspected to be related to the study drug must be reported within 7 calendar days (fatal/life-threatening) or 15 calendar days (other SAEs). Expected SAEs are reported in aggregate periodic reports.

Sponsors must maintain SAE databases and analyze patterns. Safety signals may trigger protocol amendments, labeling changes, or study termination.

Regulatory Context

This term appears most often in pharmacovigilance workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside 21 CFR 312 32, ICH E2A, ICH E6.

FDAEMAWHO

When This Matters

The SAE required 7-day expedited reporting due to fatal outcome.
The DSMB reviewed all SAEs at the interim analysis.
SAE reconciliation identified discrepancies between CRF and safety database.

Common Mistakes

Treating safety signal reviews as periodic instead of continuous.
Not linking new enforcement letters to internal CAPA and labeling workflows.
Using static templates for dynamic benefit-risk communication updates.

Related Regulations

21 CFR 312 32ICH E2AICH E6

Frequently Asked Questions

A Suspected Unexpected Serious Adverse Reaction (SUSAR) is an SAE that is both suspected to be related to the study drug and is unexpected (not listed in the Investigator's Brochure).

Inpatient hospitalization or prolongation of hospitalization qualifies as serious. Emergency room visits, outpatient surgery, and admissions for pre-planned procedures don't automatically meet the criterion.